Kestra Advisory Services’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $102K | Sell |
|
|||||
|
2025
Q3 | $99.7K | Buy |
|
|||||
|
2025
Q2 | $114K | Sell |
|
|||||
|
2025
Q1 | $95.4K | Sell |
|
|||||
|
2024
Q4 | $96.4K | Buy |
|
|||||
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $133K | Sell |
|
|||||
|
2023
Q2 | $184K | Buy |
|
|||||
|
2023
Q1 | $200K | Buy |
|
|||||
|
2022
Q4 | $247K | Buy |
|
|||||
|
2022
Q3 | $180K | Buy |
|